Quant Healthcare Fund
- NAV as on 24 Sep 2026
- ₹18.40-0.58%1 day
- Return since launch
- 21.3%
- 52-week range
- ₹13.89 — ₹18.51
- AUM
- ₹428 Cr
Quant Healthcare Fund is a Sectoral-Pharma equity fund from Quant Mutual Fund with ₹428 Cr under management, launched in 2023. Over three years it has returned 16.1% a year, against 21.1% for its category. The expense ratio is 3.12% and the SEBI riskometer reading is Very High.
Performance
Quant Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +19.6% against +17.6% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 35.0% | +16.1 pts | 18.9% | 26.8% |
| 2Y | 18.2% | +1.1 pts | 17.1% | 15.4% |
| 3Y | 16.1% | −5.1 pts | 21.1% | 16.1% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 1.6% | +0.6 pts | 1.0% | 0.9% |
| 3M | 9.9% | +2.4 pts | 7.5% | 7.1% |
| 6M | 26.3% | +4.4 pts | 21.9% | 20.5% |
| 1Y | 19.6% | +0.7 pts | 18.9% | 17.6% |
| 2Y | 4.1% | −4.2 pts | 8.3% | 6.9% |
| 3Y | 20.3% | −0.9 pts | 21.1% | 20.6% |
Since launch (27 Jun 2023): 21.3%
Calendar-year returns
Category averageShow as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -5.2% | −3.1 pts | -2.0% |
| 2024 | 29.4% | −11.5 pts | 40.9% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
3.13%
Expense ratio as on 23 Sep 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 2.10%
- Brokerage
- 0.11%
- Transaction charges
- 0.02%
- Statutory levies
- 0.90%
- Exit load
- Exit load of 1%, if redeemed within 15 days.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- NIFTY Healthcare TRI.
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
| Ratio | Fund | Category avg | Read as |
|---|---|---|---|
| Alpha | -1.80 | 0.74 | Return earned above what the benchmark alone would have given. Higher is better. |
| Beta | 0.97 | 0.93 | How hard the fund moves when the market moves. Under 1 is steadier than the market. |
| Sharpe | 0.80 | 1.05 | Return earned for each unit of total risk taken. Higher is better. |
| Sortino | 1.29 | 1.63 | Return earned for each unit of downside risk. Higher is better. |
| Std. deviation | 18.13 | 15.68 | How widely monthly returns have varied around their own average. Lower is steadier. |
| Average of 5 category peers | |||
Portfolio
Quant Healthcare Fund portfolio
Portfolio as of 31 Aug 2026
Asset allocation
- Equity99.0%
- Debt5.6%
Market cap split
- Mid44.5%
- Small55.5%
- P/E
- 33.85
- P/B
- 4.81
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | 10.58% | ₹45.31 Cr | +1.93% | +2.38% | — |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 9.83% | ₹42.09 Cr | — | — | — |
| company:18109 | Healthcare | 9.46% | ₹40.52 Cr | — | — | — |
| company:5626 | Healthcare | 9.30% | ₹39.82 Cr | — | — | — |
| Pfizer Ltd. | Healthcare | 8.83% | ₹37.81 Cr | +5.92% | +6.93% | +6.44% |
| Alivus Life Sciences Ltd | Healthcare | 8.08% | ₹34.62 Cr | +6.98% | +6.41% | +6.06% |
| company:3988 | Healthcare | 7.87% | ₹33.69 Cr | +9.45% | — | — |
| Concord Biotech Ltd. | Healthcare | 7.03% | ₹30.13 Cr | — | +2.91% | +3.66% |
| SMS Pharmaceuticals Ltd. | Healthcare | 6.71% | ₹28.73 Cr | +7.66% | +9.98% | +5.14% |
| Aurobindo Pharma Ltd. | Healthcare | 6.68% | ₹28.60 Cr | +9.89% | +10.71% | +5.04% |
| Ipca Laboratories Ltd. | Healthcare | 6.22% | ₹26.63 Cr | — | — | — |
| Zydus Wellness Ltd. | Consumer Staples | 5.64% | ₹24.18 Cr | +8.74% | +7.05% | +6.75% |
| Strides Pharma Science Ltd. | Healthcare | 2.45% | ₹10.48 Cr | +2.63% | — | — |
| Reserve Bank of India | Financial | 0.69% | ₹2.96 Cr | +0.80% | +0.85% | +0.77% |
| Sumitomo Chemical India Ltd. | Chemicals | 0.31% | ₹1.32 Cr | — | — | — |
| Others | Others | -4.55% | ₹-19.49 Cr | -50.80% | +21.26% | -26.53% |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Divi's Laboratories Ltd. | 9.93% | 0.00% | -9.93% |
| company:18109 | 0.00% | 9.46% | +9.46% |
| Others | -17.89% | -27.21% | -9.32% |
| company:5626 | 0.00% | 9.30% | +9.30% |
| Aster DM Quality Care Ltd. | 9.25% | 0.00% | -9.25% |
| HFCL Ltd. | 7.89% | 0.00% | -7.89% |
| company:3988 | 0.00% | 7.87% | +7.87% |
| Zydus Wellness Ltd. | 9.33% | 5.64% | -3.69% |
| Aurobindo Pharma Ltd. | 5.14% | 1.50% | -3.64% |
| Pfizer Ltd. | 5.82% | 8.83% | +3.00% |
| Concord Biotech Ltd. | 9.66% | 7.03% | -2.62% |
| Alivus Life Sciences Ltd | 7.19% | 8.08% | +0.89% |
| Glaxosmithkline Pharmaceuticals Ltd. | 9.93% | 10.58% | +0.65% |
| Glenmark Pharmaceuticals Ltd. | 9.21% | 9.83% | +0.62% |
| SMS Pharmaceuticals Ltd. | 7.27% | 6.71% | -0.57% |
| Ipca Laboratories Ltd. | 5.93% | 6.22% | +0.28% |
| Strides Pharma Science Ltd. | 2.64% | 2.45% | -0.19% |
| Reserve Bank of India | 0.75% | 0.69% | -0.06% |
| Sumitomo Chemical India Ltd. | 0.33% | 0.31% | -0.02% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹3,579 Cr | 2.19% | 27.6% | 18.0% | 20.3% |
 ICICI Prudential Healthcare Fund | ₹6,996 Cr | 2.07% | 14.4% | 14.4% | 19.6% |
 SBI Healthcare Opportunities Fund | ₹5,796 Cr | 1.99% | 33.3% | 20.2% | 22.4% |
 Mirae Asset Healthcare Fund | ₹3,555 Cr | 2.03% | 31.0% | 18.9% | 20.0% |
 UTI Healthcare Fund | ₹1,444 Cr | 2.21% | 30.9% | 19.5% | 21.3% |
 LIC MF Healthcare Fund | ₹103 Cr | 2.67% | 28.6% | 17.0% | 18.0% |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
Fund managers
- Ankit A PandeMr. Pande has done CFA and MBAPrior to joining Quant Mutual Fund he has worked with Infosys Finacle. Began his career in equity research in 2011.
- Ayusha KumbhatCFA Level III, BSc (Hons) in Economics, MSc in Behavioural & Experimental EconomicsShe is working with Quant Mutual fund as Research Analyst for the past 15 months, specializing in investment research.
- Sameer KateBachelor of Computer Science, MBA from IME Pune.Prior to joining Quant Mutual Fund, he was working with Investec Capital and Kotak Securities,
- Sandeep TandonMr. Tandon has done MBA (Finance)Prior to joining Quant Mutual Fund, he has worked with ICICI Securities as Vice President, The Economic Times and IDBI AMC.
- Sanjeev SharmaMr. Sharma is a Commerce Graduate and PGDBA (Finance) from Symbiosis, Pune.He has total work experience of 17 years including 13 years of experience in the financial market. He specializes in identifying crucial inflexion points in securities.
- Varun PattaniMr. Pattani is an ACAPrior to joining Quant Mutual Fund, he has worked with boutique PMS firm.
- Yug TibrewalB.M.S, CFA L1Yug is an investment professional with over 2 years of experience in dealing related activities
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months26.28% absolute | ₹60,000 | ₹75,768 | 26.28% | |
| 1 year19.60% annualised | ₹1,20,000 | ₹1,33,535 | 11.28% | |
| 3 years20.25% annualised | ₹3,60,000 | ₹4,98,075 | 38.35% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.